Treatment failure in otitis media: an analysis

R Cohen1, F de la Rocque, M Boucherat

  • 1Department of Microbiology, Intercommunal Hospital, Créteil, France.

Insights

Penicillin-resistant Streptococcus pneumoniae (PRP) frequently caused treatment failure in acute otitis media (AOM). Obligatory bacteriological sampling is recommended for antibiotic treatment failures involving PRP.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Epidemiology

Background:

  • Antibiotic resistance is a growing concern in treating common infections.
  • Penicillin-resistant pneumococci (PRP) pose a significant challenge in pediatric otitis media management.
  • High rates of antibiotic resistance are reported in specific geographical areas.

Purpose of the Study:

  • To investigate the role of PRP in treatment failures of acute otitis media (AOM).
  • To assess antibiotic susceptibility patterns of Streptococcus pneumoniae in AOM treatment failures.
  • To evaluate the impact of PRP on therapeutic outcomes in AOM.

Main Methods:

  • An epidemiological study involving 293 children with AOM treated by ENT specialists.
  • Bacteriological sampling to identify pathogens and assess antibiotic resistance.
  • Analysis of treatment outcomes in relation to isolated pathogens and their resistance profiles.

Main Results:

  • Streptococcus pneumoniae was the most common pathogen in treatment failures (55.1%).
  • Serotype 23F was the predominant S. pneumoniae strain, with 86.4% exhibiting resistance or reduced susceptibility.
  • PRP was implicated in 32 of 49 cases treated with beta-lactam antibiotics.

Conclusions:

  • Multiresistant S. pneumoniae presents a serious therapeutic challenge in AOM.
  • Myringotomy and bacteriological sampling should be mandatory for antibiotic treatment failures.
  • Amoxicillin demonstrated the most activity among oral beta-lactams against these resistant strains.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...